According to Royalty Pharma's latest financial reports the company's current earnings are A$2.23 Billion. In 2023 the company made an earning of A$2.89 Billion, an increase over its 2022 earnings that were of A$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.